Exor press release - fy24 results

Amsterdam, 26 march 2025 exor delivers 9% nav per share growth in 2024 launch of a €1 billion share buyback program with tender offer at up to 10% premium nav reached €38.2 billion at 31 december 2024, with nav per share increasing by 9% strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. active and disciplined capital allocation with increased exposure to healthcare ordinary dividend to be distributed of approximately €100 million, subject to agm approval launch of a new €1 billion share buyback program in the form of a tender offer starting 27 march 2025 at a premium of up to 10% the company will hold its annual investor and analyst call on 27 march 2025 at 15hcet € million, unless otherwise indicated 31 december 2024 1 january 2024 total assets / gross asset value (gav)(a) 42,460 39,739 equity / net asset value (nav)(a) 38,212 35,423 nav per share - €(a) 178.78 164.02 market capitalization 19,568 21,176 share price - € 88.55 90.50 net financial position(a) (3,942) (3,968) loan-to-value ratio (ltv) (%)(a) 9.6% 10.1%   years ended 31 december € million, unless otherwise indicated 2024 2023 nav per share growth (%) 9.0% 32.7% total shareholder return (%)(b) (1.7)% 33.2% msci world return index (%)(b) 24.8% 17.6%       (a)  alternative performance measure (apm) which is non-ifrs and is used to measure the company's financial performance and financial position, in line with industry, and is generally accepted by the financial community.
NAV Ratings Summary
NAV Quant Ranking